Matthew S. Gregorio MA, CCRC

Matthew S. Gregorio MA, CCRC has over 16 years of experience in the clinical research field. In 2020, they began working as a Senior Clinical Project Manager at Nocion Therapeutics, Inc., a Clinical Trial Management Consultant at Aldeyra Therapeutics, and a Consulting Clinical Trial Manager at Talaris Therapeutics. From 2015 to 2020, they were an Associate Clinical Project Manager at Acorda Therapeutics, Inc., where they were a key contributor in the Phase3 Parkinson’s Disease Program, which led to successful 505(b)(2) submission and FDA approval for INBRIJA™ (levodopa inhalation powder) drug/devise combination product, as well as the successful MMA filing and approval in the EU. From 2013 to 2015, they were a Clinical Research Coordinator (Research Assistant II) at Brigham and Women's Hospital, where they were the lead clinical research coordinator of the “Optimizing Protein in Older Americans with Mobility Limitations” (OPTIMen) Study. From 2012 to 2013, they were a Clinical Research Assistant/Clinical Research Coordinator at Boston Medical Center. Prior to that, they were an Ophthalmic Medical Technician at Jason M Gilbert MD PC from 2008 to 2012 and an Ophthalmic Medical Assistant at Stephen J. Poor III MD PC from 2004 to 2008.

Matthew S. Gregorio MA, CCRC obtained a Bachelor of Science (B.S.) in Biology, General from the University of Massachusetts Amherst between 1999 and 2003. Matthew S. then attended Boston University from 2006 to 2013, earning a Master of Arts (M.A.) in Medical Sciences and a Master of Arts (M.A.), Clinical Investigation in Clinical Research. In 2014, they became a Member of the Association of Clinical Research Professionals. In 2015, they were awarded the Certified Clinical Research Coordinator (CCRC\u00ae) certification from the Association of Clinical Research Professionals.